Jae Hyeon Park

Prof. Dr. Jae Hyeon Park

Laboratory Medicine, Seoul National University Hospital, Seoul, Republic of Korea
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2016 in Experimental and Clinical Endocrinology & Diabetes
Verified
Journal Article
Closed access
PDF file
JPJae Hyeon Park
Jae Hyeon Park
JKJ.-E. Kim
J.-E. Kim
JGJ.-Y. Gu
J.-Y. Gu
HYH. J. Yoo
H. J. Yoo
SPS. H. Park
S. H. Park
HKH. K. Kim
H. K. Kim
Background: Inflammatory stimuli can induce neutrophils to release nuclear DNA combined with histones into the extracellular space, forming neutrophil extracellular traps. Because inflammation contributes to diabetic retinopathy, it is plausible that neutrophil extracellular trap formation actively occurs in diabetic retinopathy. This case-control study investigated the clinical relevance of circulating levels of neutrophil extracellular trap components as risk factors of diabetic retinopathy, and further evaluated whether glucose induced neutrophil extracellular trap formation in vitro using whole blood from healthy volunteers. Methods: Circulating levels of DNA-histone complexes, cell free double-stranded DNA, and polymorphonuclear neutrophil elastase, considered to be markers of neutrophil extracellular trap formation, were measured in patients with diabetic retinopathy (n=28) and without (n=62) and in 28 healthy controls. Results: Circulating DNA-histone complex and polymorphonuclear neutrophil elastase levels were significantly increased in patients with diabetic retinopathy compared with those without retinopathy. Multivariable logistic regression analysis, adjusted for glycated hemoglobin levels and fasting blood glucose, revealed that DNA-histone complex and polymorphonuclear neutrophil elastase levels were significant independent risk factors of retinopathy. In vitro experiments also showed that glucose significantly increased markers of neutrophil extracellular trap formation in a dose-dependent manner. Conclusions: Markers of neutrophil extracellular trap formation were independent risk factors of diabetic retinopathy. This finding provides a new insight into the potential therapeutic and preventive approaches to dampen neutrophil extracellular trap formation.

1 January 2021 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
JYJiwon Yun
Jiwon Yun
JPJae Hyeon Park
Jae Hyeon Park
NKNamhee Kim
Namhee Kim
EREun Youn Roh
Eun Youn Roh
SSSue Shin
Sue Shin
HPHyunwoong Park
Hyunwoong Park
Yun J, et al. J Korean Med Sci. 2021 Nov;36(48):e328. https://doi.org/10.3346/jkms.2021.36.e328

24 July 2021 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
YKYong Jun Kwon
Yong Jun Kwon
Eun Jeong WonEun Jeong Won
Eun Jeong Won
SJSeok Hoon Jeong
Seok Hoon Jeong
KSKyeong Seob Shin
Kyeong Seob Shin
JSJeong Hwan Shin
Jeong Hwan Shin
JSJong Hee Shin
Jong Hee Shin
We investigated mortality and predictors of mortality due to intensive care unit-associated candidemia (ICUAC) versus non-ICUAC by Candida species. This study included all candidemia cases in 11 hospitals from 2017 to 2018 in South Korea. The all-cause mortality rates in all 370 patients with ICUAC were approximately twofold higher than those in all 437 patients with non-ICUAC at 7 days (2.3-fold, 31.1%/13.3%), 30 days (1.9-fold, 49.5%/25.4%), and 90 days (1.9-fold, 57.8%/30.9%). Significant species-specific associations with 7- and 30-day ICUAC-associated mortality were not observed. Multivariate analysis revealed that ICU admission was an independent predictor of Candida glabrata (OR, 2.07–2.48) and Candida parapsilosis-associated mortality (OR, 6.06–11.54). Fluconazole resistance was a predictor of C. glabrata-associated mortality (OR, 2.80–5.14). Lack (less than 3 days) of antifungal therapy was the strongest predictor of 7-day mortality due to ICUAC caused by Candida albicans (OR, 18.33), Candida tropicalis (OR, 10.52), and C. glabrata (OR, 21.30) compared with 30- and 90-day mortality (OR, 2.72–6.90). C. glabrata ICUAC had a stronger association with lack of antifungal therapy (55.2%) than ICUAC caused by other species (30.6–36.7%, all p < 0.05). Most predictors of mortality associated with ICUAC were distinct from those associated with non-ICUAC and were mediated by Candida species.

1 January 2021 in BioMed Research International
Verified
Journal Article
Open access
PDF file
JPJae Hyeon Park
Jae Hyeon Park
YJYujin Jang
Yujin Jang
IYInseon Yoon
Inseon Yoon
TKTaek Soo Kim
Taek Soo Kim
HPHyunwoong Park
Hyunwoong Park
Matrix‐assisted laser desorption ionization‐time of flight mass spectrometry (MALDI‐TOF MS) is widely used in clinical microbiology laboratories because it is cost‐effective, reliable, and fast. This study is aimed at comparing the identification performance of the recently developed Autof ms1000 (Autobio, China) with that of the Bruker Biotyper (Bruker Daltonics, Germany). From January to June 2020, 205 preserved strains and 302 clinical isolates were used for comparison. Bacteria were tested with duplicates of the direct transfer method, and formic acid extraction was performed if the results were not at the species level. Fungi were tested with formic acid extraction followed by ethanol extraction methods. 16S rRNA or ITS region sequence analysis was performed on isolates that could not be identified by any of the instruments and on isolates that showed inconsistent results. The time to result of each instrument was also compared. Among preserved strains, species‐level identification results were obtained in 202 (98.5%) strains by the Autof ms1000 and 200 (97.6%) strains by the Bruker Biotyper. Correct identification at the species/complex level was obtained for 200 (97.6%) strains by the Autof ms1000 and for 199 (97.1%) strains by the Bruker Biotyper. Among clinical isolates, species‐level identification results were obtained in 301 (99.7%) strains and 300 (99.3%) strains by the Autof ms1000 and Bruker Biotyper, respectively. Correct identification at the species/complex level was achieved for 299 (99.0%) strains by the Autof ms1000 and for 300 (99.3%) strains by the Bruker Biotyper. The time to analyze 96 spots was approximately 14 min for the Autof ms1000 and approximately 27 min for the Bruker Biotyper. The two instruments showed comparable performance for the routine identification of clinical microorganisms. In addition, the Autof ms1000 has a short test time, making it convenient for use in clinical microbiology laboratories.

1 November 2014 in Annals of Laboratory Medicine
Verified
Journal Article
Open access
JPJae Hyeon Park
Jae Hyeon Park
BWBo-Mee Woo
Bo-Mee Woo
SHSung Kuk Hong
Sung Kuk Hong
EKEui-Chong Kim
Eui-Chong Kim

1 February 2025 in JAMA Pediatrics
Verified
Journal Article
Open access
DLDa Hye Lee
Da Hye Lee
HKHwa Young Kim
Hwa Young Kim
JPJi Young Park
Ji Young Park
JKJae Hyun Kim
Jae Hyun Kim
JPJae Hyeon Park
Jae Hyeon Park
Importance: Whether COVID-19 contributes to youth-onset diabetes is controversial, and research in Asia is lacking.Objective: To explore the incidence and severity of diabetes among youths during the COVID-19 pandemic in South Korea.Design, Setting, and Participants: This cohort study used claims data for January 1, 2017, through February 28, 2022, from the National Health Insurance Service database in South Korea. The incidence of type 1 diabetes (T1D) and type 2 diabetes (T2D) in patients younger than 20 years during the pandemic was analyzed and compared with that during the prepandemic period. The study included incident cases of T1D identified by at least 2 diagnosis codes with at least 2 insulin prescriptions within 1 year and T2D identified by at least 2 diagnosis codes with at least 2 prescriptions of diabetes medication within 1 year. Analyses were performed between January 29 and September 2, 2024.Exposures: COVID-19 pandemic and SARS-CoV-2 infection.Main Outcomes and Measures: The primary outcome was incidence of T1D and T2D, and secondary outcomes included the rate of diabetic ketoacidosis (DKA) and association of new-onset diabetes with SARS-CoV-2 positivity.Results: The study included 2599 patients with T1D (mean [SD] age, 12.0 [4.8] years; 1235 [47.5%] male) and 11 040 patients with T2D (mean [SD] age, 16.0 [2.8] years; 6861 [62.1%] male). During the pandemic, the incidence rate ratios were 1.19 (95% CI, 1.10-1.29) for T1D and 1.41 (95% CI, 1.36-1.46) for T2D. The incidence rate of DKA at diagnosis increased during the first pandemic year compared with the prepandemic period (T1D, 42.8% [95% CI, 38.5%-47.0%] vs 31.3% [95% CI, 29.0%-33.7%], respectively; T2D, 6.0% [95% CI, 5.0%-7.1%] vs 2.9% [95% CI, 2.5%-3.3%], respectively) but returned to prepandemic levels in the second pandemic year (T1D, 34.5% [95% CI, 30.6%-38.5%]; T2D, 3.2% [95% CI, 2.6%-3.9%]). The hazard ratio for new-onset diabetes associated with SARS-CoV-2 positivity was 0.44 (95% CI, 0.17-1.13) for T1D and 1.08 (95% CI, 0.74-1.57) for T2D.Conclusions and Relevance: These findings suggest that the incidence and severity of T1D and T2D among South Korean youths increased during the COVID-19 pandemic. The cohort analysis does not support SARS-CoV-2 infection itself as being directly associated with incident diabetes.